An activated partial thromboplastin clotting time (APTT) can be abnormal in a heterogeneous group of disorders. Risks associated with a prolonged APTT include hemorrhage or thrombosis, or the prolongation can have no hemostatic consequence. An abnormal APTT should always be evaluated within the context of the patient’s clinical history.
Recent Stories for Education
Mayo Clinic will be hosting the symposium, “Data-Driven Algorithms for Optimizing Laboratory Test Utilization for Hematologic Malignancies,” on Friday, Dec. 5, in San Francisco from 7:30-11 a.m., preceding the 56th American Society of Hematology Annual Meeting.
The composition of a kidney stone can be an important diagnostic detail. When kidney stone specimens are submitted in less than optimal conditions, it delays analysis and may actually impact the analytic outcome. Proper preparation prior to submitting the specimen can greatly improve both turnaround time and accuracy.
Other Posts for Education
- Mycobacteria Part 3: Drug Susceptibility Testing for Mycobacterium tuberculosis Complex [Hot Topic]
- Mayo Clinic to Host Three Educational Symposia at AHA Scientific Sessions 2014
- Laboratory Identification of Lupus Anticoagulant: Guidelines and Recommendations [Communiqué]
- Mycobacteria Part 2: Identification of Mycobacterium tuberculosis Complex [Hot Topic]
- Mycobacteria Part 1: Stains and Culture [Hot Topic]
- Enterovirus Infection and Its Association with Severe Respiratory Disease [Hot Topic]
- Leveraging the Laboratory 2014 Summary
- Utilization Management 2014 Summary
- Validation/Verification of Multi-Target Tests in Microbiology [Hot Topic]
- Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines [Communiqué]